ZTS Q2 2020 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

Q2 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.5B+0.1% YoY

Gross Profit

$1.1B68.3% margin

Operating Income

$553M35.7% margin

Net Income

$377M24.4% margin

EPS (Diluted)

$0.79

QoQ Revenue Growth

+0.9%

Cash Flow

Operating Cash Flow

$438M

Free Cash Flow

$348M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$13.1B

Total Liabilities

$10.1B

Stockholders' Equity

$3.0B

Cash & Equivalents

$3.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.5B	+0.1%
Gross Profit	$1.1B	$1.0B	+1.3%
Operating Income	$553M	$526M	+5.1%
Net Income	$377M	$371M	+1.6%

Revenue Segments

Dogs and Cats

$831M55%

Cattle

$320M21%

Swine

$146M10%

Poultry

$135M9%

Horses

$51M3%

Fish

$30M2%

Geographic Segments

United States Segment

$823M54%

International Segment

$708M46%